These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7163640)

  • 21. Effect of pretreatment with spironolactone, phenobarbital or -diethylaminoethyl diphenylpropylacetate (SKF 525-A) on tritium levels in blood, heart and liver of rats at various times after administration of ( 3 H)digitoxin.
    Castle MC; Lage GL
    Biochem Pharmacol; 1972 May; 21(10):1449-55. PubMed ID: 5029425
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of spironolactone pretreatment on digitoxin metabolism in isolated hepatocytes from male and female rats.
    Ohta M; Sato Y; Kitani K
    Biochem Pharmacol; 1982 Jun; 31(12):2192-4. PubMed ID: 7115439
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro metabolism of 4-vinylcyclohexene in rat and mouse liver, lung, and ovary.
    Keller DA; Carpenter SC; Cagen SZ; Reitman FA
    Toxicol Appl Pharmacol; 1997 May; 144(1):36-44. PubMed ID: 9169067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
    Cook CS; Hauswald C; Oppermann JA; Schoenhard GL
    J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NADPH-dependent formation of aflatoxicol by mouse and rat lungs in vitro.
    Emerole GO; Thabrew MI
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):567-70. PubMed ID: 7255887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholestyramine and spironolactone and their combination in digitoxin elimination.
    Carruthers SG; Dujovne CA
    Clin Pharmacol Ther; 1980 Feb; 27(2):184-7. PubMed ID: 7353337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of phenobarbital and spironolactone pretreatment on digitoxin-induced mortality in male and female rats.
    Talcott RE; Stohs SJ
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):86-8. PubMed ID: 4746634
    [No Abstract]   [Full Text] [Related]  

  • 29. Mode of action of butoxyethanol-induced mouse liver hemangiosarcomas and hepatocellular carcinomas.
    Klaunig JE; Kamendulis LM
    Toxicol Lett; 2005 Mar; 156(1):107-15. PubMed ID: 15705491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dehydro-digitoxosides of digitoxigenin: formation and importance for the digitoxin metabolism in the rat.
    Schmoldt A; Rohloff C
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):167-72. PubMed ID: 732892
    [No Abstract]   [Full Text] [Related]  

  • 31. Purification of a rat liver cytosolic sulfotransferase responsible for the conjugation of digitoxigenin.
    Johannes A; von Meyerinck L; Schmoldt A
    Biochem Pharmacol; 1990 Jan; 39(2):301-7. PubMed ID: 2302255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible mechanism of the prevention of digitoxin toxicity by spironolactone in the mouse.
    Buck SH; Lage GL
    Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):192-7. PubMed ID: 5130149
    [No Abstract]   [Full Text] [Related]  

  • 33. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
    Halpin RA; Ulm EH; Till AE; Kari PH; Vyas KP; Hunninghake DB; Duggan DE
    Drug Metab Dispos; 1993; 21(6):1003-11. PubMed ID: 7905377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in normal subjects.
    Graves PE; Fenster PE; MacFarland RT; Marcus FI; Perrier D
    Clin Pharmacol Ther; 1984 Nov; 36(5):601-6. PubMed ID: 6488680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: On the digitoxin metabolism by rat liver microsomal enzymes.
    Schmoldt A; Benthe HF
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R41. PubMed ID: 238152
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of spironolactone and norbolethone on the toxicity of digitalis compounds in the rat.
    Selye H; Mécs I; Tamura T
    Br J Pharmacol; 1969 Oct; 37(2):485-8. PubMed ID: 5364266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species differences in pharmacokinetic and pharmacodynamic properties of nebicapone.
    Bonifácio MJ; Loureiro AI; Torrão L; Fernandes-Lopes C; Wright L; Pinho MJ; Soares-da-Silva P
    Biochem Pharmacol; 2009 Oct; 78(8):1043-51. PubMed ID: 19505437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digitoxin metabolism by rat liver microsomes.
    Schmoldt A; Benthe HF; Haberland G
    Biochem Pharmacol; 1975 Sep; 24(17):1639-41. PubMed ID: 10
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.